Delivery Order SPE2DX22D0010-SPE2D825FFF05
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$4.5K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,598.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 30, 2024. The contract covers the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,672.80 firm-fixed-price contract is for the supply of MYDAYIS CAPS 37.5MG, a prescription medication. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen, through its Corporate Office division, is a significant provider of pharmaceuticals and medical supplies to the U.S. federal...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,037.41, is a delivery order (SPE2DX15D3017|SPE2DX24F0JKT) with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4558864418 MYDAYIS ER 37.5 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,030.51 and a completion date of October 21, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,401.62, is for the delivery of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $1,107.02 firm fixed price delivery order is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,123.72 Firm Fixed Price Delivery Order (SPE2DX15D1053|SPE2DX24F6PQH) is for the supply of MYDAYIS ER 12.5 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of July 2, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,087.34 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract covers the provision of MYDAYIS ER 25 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through October 28, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMNQW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,145.28 and a period of performance through April 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of MYDAYIS ER 25 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,087.34 firm fixed price delivery order has a completion date of July 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical...